{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (FY2026 Q4)",
      "prediction": "BEAT",
      "answer": "pred ~$8.43 vs. cons $8.31",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue (FY2026 Q4)",
      "prediction": "IN-LINE",
      "answer": "pred ~$5.62B vs. cons $5.58B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted segment operating margin (FY2026 Q4)",
      "prediction": "IN-LINE",
      "answer": "pred ~27.6% vs. cons 27.4%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted EPS guidance",
      "prediction": "LOWER",
      "answer": "guide ~$33.60 vs. cons $34.01 (FY2027)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$22.60B vs. cons $22.68B (FY2027)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic sales growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~5.5% vs. cons 5.5% (FY2027)",
      "confidence": "LOW"
    },
    {
      "kpi": "Adjusted segment operating margin guidance",
      "prediction": "LOWER",
      "answer": "guide ~27.6% vs. cons 27.7% (FY2027)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -2.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.3,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A modest Q4 beat is likely outweighed by FY2027 adjusted EPS guidance of ~$33.60 versus consensus of $34.01 and margin guidance of ~27.6% versus 27.7%; the resulting out-period estimate cuts should extend the negative residual move rather than produce a quick fade.",
  "day5_confidence": "MEDIUM"
}